• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Find the best oral migraine drugs for you

November 20, 2024
in Medical Research
Reading Time: 4 mins read
A A
0
Find the best oral migraine drugs for you
6
SHARES
13
VIEWS
Share on FacebookShare on Twitter


Migraine research has made huge strides in the last few years, but with so many treatment options available, it can be difficult to know where to start. Let us help you find the best oral migraine medication for you.

Danish Deep Cut

In a massive meta-analysis of over 100 research studies, Danish docs put together a list of the best, most effective migraine pills. This 2024 study compared all licenced oral drugs for adults with migraines and identified which worked the best in terms of overall pain relief, safety, and tolerability.1

Researchers included the more recently approved oral migraine drugs (lasmiditan, rimegepant, ubrogepant) along with more widely used medications.1 They found that these newer drugs work about as well as paracetamol and most non-steroidal anti-inflammatory drugs (NSAIDs).1 Triptans, on the other hand seemed to be more useful but widely under prescribed.1

If you and your doctor are developing a personal pain plan, you are in the right place. We’ve analyzed the analysis to help you figure out which combination of efficacy, speed of action and side effects is best for you.

So, get ready for our remedy ranking!

Best for immediate pain relief

When ranked for fast-acting pain relief (2 hours after the dose), the top five migraine pills were:

  1. Eletriptan
  2. Rizatriptan
  3. Sumatriptan
  4. Zolmitriptan
  5. Frovatriptan

Triptans for the win here!

Best for sustained pain relief

When ranked for fast-acting pain relief (2 hours after the dose), the top five migraine pills were:

  1. Ibuprofen
  2. Eletriptan
  3. Rizatriptan
  4. Sumatriptan
  5. Zolmitriptan

Triptans for the win again! Mostly. 

Best oral migraine meds for overall safety and tolerability 

When ranked for overall safety and tolerability (dizziness, nausea, sedation, fatigue), the top five migraine pills were:

  1. Paracetamol
  2. Naratriptan/Frovatriptan
  3. Almotriptan
  4. Ibuprofen
  5. Celecoxib

This is more of a mix. Different types of drugs may be better at combating different symptoms, so let’s break it down for each type of side effect.

The drugs least associated with dizziness:

  1. Naratriptan
  2. Frovatriptan/Paracetamol
  3. Almotriptan/Celecoxib
  4. Ibuprofen/Naproxen sodium
  5. Rimegepant

The drugs least associated with nausea:

  1. Paracetamol
  2. Ibuprofen
  3. Frovatriptan
  4. Naratriptan
  5. Celecoxib

The drugs least associated with sedation (sleepiness):

  1. Frovatriptan
  2. Naratriptan
  3. Paracetamol
  4. Almotriptan
  5. Ibuprofen

The drugs least associated with fatigue:

  1. Almotriptan
  2. Paracetamol
  3. Naratriptan
  4. Frovatriptan
  5. Phenazone

While certain triptans do make an appearance on each of these lists, not all triptans are created equal. 

According to the researchers, dizziness was more commonly associated with triptans like  eletriptan, sumatriptan, and zolmitriptan; fatigue and sedation were more commonly associated with eletriptan; and nausea was most commonly associated with sumatriptan and zolmitriptan.1

How were the oral migraine drugs assessed and ranked

We know MNB readers don’t just take our word for things so let me walk you through how we used the data from the researchers to create these rankings.

Seventeen migraine drugs were compared on efficacy and tolerability 

Efficacy was assessed by pain relief:

  • The proportion of patients who were pain-free at 2 hours after the dose
  • The proportion of patients who were pain free from 2-24 hours after the dose

Key safety and tolerability characteristics were:

  • Dizziness
  • Nausea
  • Sedation
  • Fatigue

The researchers compared the efficacy and safety of these drugs relative to each other (a head-to-head analysis) and provided the data in Figures 4 and 5 of the paper.1 Based on those individual numbers I created 6 ranked lists: two for each of the efficacy criteria, and four for the safety criteria. 

Drugs that were ranked higher were the ones that were better at providing pain relief and least associated with side effects. 

For the overall safety ranking, I averaged the rankings for each drug to see which ones were better across all four safety and tolerability categories. 

Now, this meta-analysis only included oral drugs. Not only are there other methods of treatment for migraines (such as botox injections), but new therapies are regularly appearing on the scene (see our stories on atogepant and sex hormones).

Hopefully, this breakdown helps you get started on a conversation about the treatment options available to you!

References

1. Karlsson WK, Ostinelli EG, Zhuang ZA, et al. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis. BMJ. Published online September 18, 2024:e080107. doi:10.1136/bmj-2024-080107




Migraine research has made huge strides in the last few years, but with so many treatment options available, it can be difficult to know where to start. Let us help you find the best oral migraine medication for you.

Danish Deep Cut

In a massive meta-analysis of over 100 research studies, Danish docs put together a list of the best, most effective migraine pills. This 2024 study compared all licenced oral drugs for adults with migraines and identified which worked the best in terms of overall pain relief, safety, and tolerability.1

Researchers included the more recently approved oral migraine drugs (lasmiditan, rimegepant, ubrogepant) along with more widely used medications.1 They found that these newer drugs work about as well as paracetamol and most non-steroidal anti-inflammatory drugs (NSAIDs).1 Triptans, on the other hand seemed to be more useful but widely under prescribed.1

If you and your doctor are developing a personal pain plan, you are in the right place. We’ve analyzed the analysis to help you figure out which combination of efficacy, speed of action and side effects is best for you.

So, get ready for our remedy ranking!

Best for immediate pain relief

When ranked for fast-acting pain relief (2 hours after the dose), the top five migraine pills were:

  1. Eletriptan
  2. Rizatriptan
  3. Sumatriptan
  4. Zolmitriptan
  5. Frovatriptan

Triptans for the win here!

Best for sustained pain relief

When ranked for fast-acting pain relief (2 hours after the dose), the top five migraine pills were:

  1. Ibuprofen
  2. Eletriptan
  3. Rizatriptan
  4. Sumatriptan
  5. Zolmitriptan

Triptans for the win again! Mostly. 

Best oral migraine meds for overall safety and tolerability 

When ranked for overall safety and tolerability (dizziness, nausea, sedation, fatigue), the top five migraine pills were:

  1. Paracetamol
  2. Naratriptan/Frovatriptan
  3. Almotriptan
  4. Ibuprofen
  5. Celecoxib

This is more of a mix. Different types of drugs may be better at combating different symptoms, so let’s break it down for each type of side effect.

The drugs least associated with dizziness:

  1. Naratriptan
  2. Frovatriptan/Paracetamol
  3. Almotriptan/Celecoxib
  4. Ibuprofen/Naproxen sodium
  5. Rimegepant

The drugs least associated with nausea:

  1. Paracetamol
  2. Ibuprofen
  3. Frovatriptan
  4. Naratriptan
  5. Celecoxib

The drugs least associated with sedation (sleepiness):

  1. Frovatriptan
  2. Naratriptan
  3. Paracetamol
  4. Almotriptan
  5. Ibuprofen

The drugs least associated with fatigue:

  1. Almotriptan
  2. Paracetamol
  3. Naratriptan
  4. Frovatriptan
  5. Phenazone

While certain triptans do make an appearance on each of these lists, not all triptans are created equal. 

According to the researchers, dizziness was more commonly associated with triptans like  eletriptan, sumatriptan, and zolmitriptan; fatigue and sedation were more commonly associated with eletriptan; and nausea was most commonly associated with sumatriptan and zolmitriptan.1

How were the oral migraine drugs assessed and ranked

We know MNB readers don’t just take our word for things so let me walk you through how we used the data from the researchers to create these rankings.

Seventeen migraine drugs were compared on efficacy and tolerability 

Efficacy was assessed by pain relief:

  • The proportion of patients who were pain-free at 2 hours after the dose
  • The proportion of patients who were pain free from 2-24 hours after the dose

Key safety and tolerability characteristics were:

  • Dizziness
  • Nausea
  • Sedation
  • Fatigue

The researchers compared the efficacy and safety of these drugs relative to each other (a head-to-head analysis) and provided the data in Figures 4 and 5 of the paper.1 Based on those individual numbers I created 6 ranked lists: two for each of the efficacy criteria, and four for the safety criteria. 

Drugs that were ranked higher were the ones that were better at providing pain relief and least associated with side effects. 

For the overall safety ranking, I averaged the rankings for each drug to see which ones were better across all four safety and tolerability categories. 

Now, this meta-analysis only included oral drugs. Not only are there other methods of treatment for migraines (such as botox injections), but new therapies are regularly appearing on the scene (see our stories on atogepant and sex hormones).

Hopefully, this breakdown helps you get started on a conversation about the treatment options available to you!

References

1. Karlsson WK, Ostinelli EG, Zhuang ZA, et al. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis. BMJ. Published online September 18, 2024:e080107. doi:10.1136/bmj-2024-080107



Tags: migrainepatient empowermentself-care
Previous Post

Call for entries: The Earthshot Prize 2025 – Seeking groundbreaking solutions to restore our planet – Africa.com

Next Post

Watchdog Group Says Investigation Into Abuses by African Parks Is Tainted

Related Posts

Comparable effectiveness seen for multiartery bypass grafting methods

February 7, 2026
3

Gambling impacts people's quality of life as severely as chronic medical conditions, alcohol and illegal drugs

February 7, 2026
2
Next Post

Watchdog Group Says Investigation Into Abuses by African Parks Is Tainted

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024
Marcos Mostly Got What He Wanted Out of Trump

Marcos Mostly Got What He Wanted Out of Trump – The Diplomat

August 4, 2025
Prince George man found guilty of 1st-degree murder in stabbing death of young mother

Prince George man found guilty of 1st-degree murder in stabbing death of young mother

November 11, 2025
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

February 7, 2026
Is Nigeria’s security situation worsening, or is there progress?

Is Nigeria’s security situation worsening, or is there progress?

February 7, 2026
American fugitive who spent decades in Toronto extradited back to U.S.

American fugitive who spent decades in Toronto extradited back to U.S.

February 7, 2026

Alibaba Group Debuts “Wonder on Ice,” an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026

February 7, 2026

Recent News

How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

February 7, 2026
1
Is Nigeria’s security situation worsening, or is there progress?

Is Nigeria’s security situation worsening, or is there progress?

February 7, 2026
1
American fugitive who spent decades in Toronto extradited back to U.S.

American fugitive who spent decades in Toronto extradited back to U.S.

February 7, 2026
2

Alibaba Group Debuts “Wonder on Ice,” an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026

February 7, 2026
3

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

How old is Chinese civilisation? It really dates back 8,000 years, an archaeologist argues

February 7, 2026
Is Nigeria’s security situation worsening, or is there progress?

Is Nigeria’s security situation worsening, or is there progress?

February 7, 2026
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co